{"id":45951,"date":"2022-07-08T08:01:54","date_gmt":"2022-07-08T06:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/"},"modified":"2022-07-08T08:01:54","modified_gmt":"2022-07-08T06:01:54","slug":"slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/","title":{"rendered":"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy"},"content":{"rendered":"
\n

EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with OLS \u2013 OMNI Life Science. OLS is your partner for solutions in Flow Cytometry, Cell Culture, Cell Counting, Imaging, and Cell Analysis. We offer innovative systems for the entire workflow of cell research: From cell culture to real-time cell analysis, cell counting, and microbiology.\n<\/p>\n

<\/a><\/p>\n

\nThe agreement entitles OLS the rights to distribute and resell Slingshot Bio\u2019s products in Germany, Austria, Switzerland, and Italy. Through OLS\u2019s network of customers, Slingshot Bio will be able to establish its presence in the Germany, Austria, Switzerland, and Italy market with the well-established presence and expertise of OLS who has been selling into the flow cytometry industry for many years.\n<\/p>\n

\n\u201cOLS\u2019s network will provide us with the market penetration needed to reach our full sales potential. Slingshot Biosciences has considered many distribution partners and we are confident that OLS\u2019s extensive knowledge in the field, prominent presence and large customer base will help us leverage our position in the flow cytometry market<\/i>,\u201d said Jeffrey Kim, CEO & Founder, Slingshot Biosciences, Inc.\n<\/p>\n

\nSlingshot Bio\u2019s synthetic cellular controls provide consistent, precise, accurate control for research users in the flow cytometry space by mimicking blood properties as detected by flow cytometry. The ability to manufacture consistent controls for flow cytometry has been missing for decades and is now accurately reproducible with Slingshot Bio\u2019s unique manufacturing platform. \u201cSlingshot Bio\u2019s synthetic cells greatly empower and round off our flow cytometry portfolio, which is a central pillar of OLS,<\/i>\u201d said Andreas Friese, COO of OMNI Life Science. \u201cOur company identity entails a great focus on innovation, precision, and reproducibility, and our newly established partnership with Slingshot Bio enables us to support labs during the entirety of their workflow while maintaining high scientific standards.<\/i>\u201d\n<\/p>\n

\nAbout Slingshot Biosciences, Inc.\n<\/p>\n

\nFounded in 2012, Slingshot Biosciences is a fast-growing life sciences company with a platform technology and paradigm-shifting mission to make synthetic cells the gold standard for all cell-based applications\u2014including diagnostics, and adoptive cell therapy development and instrument calibration. Learn more at www.slingshotbio.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCaitlin Farquhar
\n
pr@slingshotbio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with OLS \u2013 OMNI Life Science. OLS is your partner for solutions in Flow Cytometry, Cell Culture, Cell Counting, Imaging, and Cell Analysis. We offer innovative systems for the entire workflow of cell … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45951","6":"format-standard","7":"category-industry"},"yoast_head":"\nSlingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with OLS \u2013 OMNI Life Science. OLS is your partner for solutions in Flow Cytometry, Cell Culture, Cell Counting, Imaging, and Cell Analysis. We offer innovative systems for the entire workflow of cell ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-08T06:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220707005073\/en\/1506250\/21\/primary_small_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy\",\"datePublished\":\"2022-07-08T06:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/\"},\"wordCount\":386,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005073\\\/en\\\/1506250\\\/21\\\/primary_small_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/\",\"name\":\"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005073\\\/en\\\/1506250\\\/21\\\/primary_small_logo.jpg\",\"datePublished\":\"2022-07-08T06:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005073\\\/en\\\/1506250\\\/21\\\/primary_small_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220707005073\\\/en\\\/1506250\\\/21\\\/primary_small_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/","og_locale":"en_US","og_type":"article","og_title":"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy - Pharma Trend","og_description":"EMERYVILLE, Calif.–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC. the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with OLS \u2013 OMNI Life Science. OLS is your partner for solutions in Flow Cytometry, Cell Culture, Cell Counting, Imaging, and Cell Analysis. We offer innovative systems for the entire workflow of cell ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-08T06:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220707005073\/en\/1506250\/21\/primary_small_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy","datePublished":"2022-07-08T06:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/"},"wordCount":386,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005073\/en\/1506250\/21\/primary_small_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/","url":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/","name":"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220707005073\/en\/1506250\/21\/primary_small_logo.jpg","datePublished":"2022-07-08T06:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220707005073\/en\/1506250\/21\/primary_small_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220707005073\/en\/1506250\/21\/primary_small_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/slingshot-biosciences-inc-partners-with-ols-omni-life-science-to-distribute-synthetic-cells-throughout-germany-austria-switzerland-and-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Slingshot Biosciences, Inc. Partners with OLS \u2013 OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45951"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45951\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}